Teva's Generic Bowel Drug Infringes Patent, Allergan Says
Allergan USA and Forest Laboratories sued Teva Pharmaceuticals USA Inc. in Delaware federal court on Friday over intellectual property behind the gastrointestinal medicine Linzess....To view the full article, register now.
Already a subscriber? Click here to view full article